SPARTACUS receives new NIH R21 funding
The two-year NHLBI-funded project will study stroke prevention using artificial intelligence and risk targeting in anticoagulated care.
Dr. Bagci has received a new NIH R21, titled SPARTACUS. We are grateful to NHLBI for this 2-year high risk high reward project funding.
SPARTACUS: Stroke Prevention with Artificial Intelligence and Risk Targeting in
Anticoagulated Care for Unique Solutions
We would like to thank Dr. Bagci’s two postdocs who were the main drivers of this grant: Vanshali Sharma and Vedat çiçek, and our close collaborator Amir Rahsepar
